MedRx Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-925	-802	-930	-1,109	-1,058
Depreciation & Amortization	13	38	45	46	60
Loss (Gain) From Sale of Investments	-	68	-	-	-
Other Operating Activities	-	49	-	-	8
Change in Inventory	-6	-	-1	3	8
Change in Accounts Payable	-37	-	-58	32	52
Change in Other Net Operating Assets	67	-156	31	-45	7
Operating Cash Flow	-888	-803	-913	-1,073	-923
Capital Expenditures	-82	-	-	-1	-2
Other Investing Activities	-	-3	-	-	-
Investing Cash Flow	-82	-3	-	-1	-2
Long-Term Debt Issued	-	-	-	-	550
Total Debt Issued	-	-	-	-	550
Short-Term Debt Repaid	-	-	-	-	-50
Long-Term Debt Repaid	-	-	-	-	-550
Total Debt Repaid	-	-	-	-	-600
Net Debt Issued (Repaid)	-	-	-	-	-50
Issuance of Common Stock	745	1,066	1,639	356	865
Financing Cash Flow	745	1,066	1,639	356	815
Foreign Exchange Rate Adjustments	2	-3	1	9	1
Miscellaneous Cash Flow Adjustments	1	-1	-1	-	1
Net Cash Flow	-222	256	726	-709	-108
Free Cash Flow	-970	-803	-913	-1,074	-925
Free Cash Flow Margin	-757.81%	-312.45%	-3148.28%	-1820.34%	-11562.50%
Free Cash Flow Per Share	-18.05	-18.47	-26.25	-42.34	-43.31
Cash Interest Paid	-	-	-	-	1
Cash Income Tax Paid	3	4	2	2	1
Levered Free Cash Flow	-660.75	-481.63	-569.75	-652.13	-529.75
Unlevered Free Cash Flow	-660.75	-481.63	-569.75	-652.13	-529.13
Change in Working Capital	24	-156	-28	-10	67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.